ML20008D465

From kanterella
Jump to navigation Jump to search
Intervenor Exhibit I-SALP-A,consisting of 890626 Surrebuttal Testimony of Ba Burrows on Issues Re MS-1 Hosps, Recreation/Decontamination Ctrs & FEMA MS-1 Guidance. Ba Burrows Curriculum Vitae Encl
ML20008D465
Person / Time
Site: Seabrook  NextEra Energy icon.png
Issue date: 06/27/1989
From: Burrows B
BACKUS, MEYER & SOLOMON, BOSTON UNIV. MEDICAL CENTER, BOSTON, MA, SEACOAST ANTI-POLLUTION LEAGUE
To:
References
CON-#190-9971 OL-I-SAPL-A, NUDOCS 9003020297
Download: ML20008D465 (23)
v • d • e


Text

-

g..

~ bY ~ -

. som y w oc t

/27

0CKLIED USNRC 10 J8118 PS $3 UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION OFICE OF SECRfiARY 00CKEllHG & SERVICl.

ATOMIC SAFETY AND LICENSING BOARD BRANCH-Before the Administrative Judges Ivan W. Smith, Chairman Dr. Richard F. Cole Kenneth A. McCollom

)

In ~ the Matter of ) Docke t Nos. 50-445-OL

, )

PUBLIC SERVICE COMPANY ) (Off-Site EP) c 0F NEW HAMPSHIRE, ET AL. )

)

(Seabr'ook .S tation, Uni t 1) ) June 26, 1989

)

SURREBUTTAL TESTIMONY OF BELTON A. BURROWS, MD ON ISSUES RE: MS-1 HOSPITALS, RECEPTION /.

DECONTAMINATION CENTERS.AND FEMA (GM) MS-l' GUIDANCE s Seacoast Anti-Pollution League By its attorney, ,

BACKUS, HEYER & SOLOMON 116 Lowell Street P.O. Box 516 Manchester, N.H. 03105 I

o ADOCK 05000443 l PDR J 6N/d 77 4

G \ -...

Y_C :

7 1. Q.: L Would you-please state your name, current positions and relevant experience?

A. My name-is Belton A. Burrows, MD. I am currently Chief of Nuclear Medicine at the Boston VA Hospital and Research Professor of Medicine I -at Boston University School of Medicine. 1 have worked with both~

research and clinical applications of radionuclides for 40 years.

2. Q. Have you reviewed materials related to the radiologicni emergency
  • response plans for Seabrook Station?

A. Yes, 1 have. I have reviewed sections of the Seabrook Plan for L

Massachusetts Communities (SPMC) related to Reception / Decontamination Centers, SPMC 1mplementing Procedure 2.9 " Radiological Monitoring / Decontamination", SPMC 1mplementing Procedure 3.4

" Monitoring Trailer Activation and Deactivation", and FEMA Guidance -

- Memorandum-(GM) MS-1, Medical Services, dated November 13, 1986. I have also reviewed pages 52-64 of the Applicants' Rebuttal Testimony No. 6 (Protective Actions for Particular Populations)'and Applicants' Rebuttal Testimony No. 17 (Radiological Monitoring Process).

3. Q. Taking up first the subject of the FEMA Guidance Memorandum (GM) MS-1 Medical Services, do you agree with the statement that Joint Commission on .'.ccreditation of Hospitals (JCAH) accreditation suffices to assure that medical f acilities have adequate technical inforration, professional support and treatment capabilities for handling

" contaminated injured"' individuals?

A. No. JCAH accreditation in and of itself does not suffice to provide assurance that a hospital will be prepared to offer such services. The

'. rearon for that'is that a hospital can obtain JCAH accreditation even if

~

~ it does not have its own Nuclear Medicine Service as long as that hospital has_ an agreement with another hospital that does have a Nucicar Medicine Service which is accredited to provide such services.

4. Q. Is having one physician and one nurse on call within about 2 hours2.314815e-5 days <br />5.555556e-4 hours <br />3.306878e-6 weeks <br />7.61e-7 months <br /> at both_ an MS-1 hospital and back-up hospital, who can supervise the evaluation and treatment of radiologically " contaminated injured" members of the ' general public, a strict enough planning requirement f or assuring medical treatment preparedness for nucicar plant accidents?

A. No. I do not think-it is sufficient. I-believe that that is a level of preparedness that does not approach what is reasonably' attainable.

Further, I think that the expertise of the medical st.aff needs more definition.

s

5. Q. Does the f act that a physician is a board certified radiologist qualify him or her to supervise a hospital response to a radiological emergency?'

A. 'That cannot necessarily be assumed. It could be that a particular individual with such certification might be sufficiently knowledgeabic,

~but the title " board certified radiologist" does not assure that the person holding such title is equipped with specific enough knowledge of radiobiology and radionuclides for handling radiological emergencies.

6. Q. Do you believe that two MS-1 hospitals provide a suf ficient level of planning on the Massachusetts side of the border for a site 11%e the Seabrook site?

A. - No. Even if only 10% of the estimated number of evacuees were referred

I * .: i,

~

from the Reception Centers to the two designated MS-1 hospitals, it would overtax those f acilities as they are described in the Applicants' testimony. From the population estimates it is clear that two hospitals would not be sufficient.

The FEMA document (GM) MS-1 does not provide sufficient guidelines for the number and capabilities of hospitals. Simply requiring an agreement with two hospitals does not alone provide a meaningful planning standard.

7. Q. Moving on to the issues regarding the Reception / Decontamination Centers, do you have specific concerns about them?

A. I am concerned that the plan does not have trained medical personnel there to make referrals for further treatment when needed. I believe that each individual who has suspected contamination needs medical follow-up services since one cannot rule out the possibility .of significant body burdens with only a surface scan. The surface scan W

. serves the important function of indicating that an individual has been exposed to excess environmental radioactivity, but further checking of an individual is called for if there has been a contaminating release, i

8. -Q. Does the Applicants' plan to register the evacuees at - the f Reception / Decontamination Centers for . inclusion in a tracking program alleviate your concerns in that regard? _

> A. No. It does not. It will require medical judgment based upon sufficient inf orma tion .to de te'rmine whether or not there is the necessity for immediate medical referral for individual evacuees. The possibility of internal body burdens must be addressed. )

i

4, -

g_

+.

i 9.-Q. What could be done to improve the Reception / Decontamination Centers to address the concerns you have raised?

A. Each Reception / Decontamination Center should have a portable pulse height analyzer with a sensitive sodium iodide detector so that the radionuclides making up the contamination can be identif f ed and treatment planned accordingly. Using spectral analysis, one can determine which radionuclides are making up the contaminants"

" fingerprints". If chelation or other therapies are advisabic given the results of the analysis, they should be instituted within as little as

, _, an hour or so.

10. Q. Would you expect body burdens in a radiological emergency where contaminants escape from the plant in a plume?

A. Yes, I would. Even ruling out the ingestion of contaminated water and foodstuf f s, one would still expect internal body burdens due to inhalation and skin absorption.

-11. Q. What if only noble gases were released in an accident? Would that not relieve your concerns about internal body burdens?

A. No. Certain of the decay products of noble gases can pose a biological-hazard. Certain radionuclides of Xenon, for example, decay to Cesium, an element which is a biological analogue of potassium. Cesium 137, with a 30 year half-life, constitutes 18% of the long-lived fission products and because of its biological and physical properties may present a radiation hazard significantly greater than conventional dosimetry would suggest.

',- 1, 6-

\

-i.,

12. Q. Putting aside your concern about internal body burdens, do you believe that the Reception / Decontamination Centers as they are presently set up under the plon'could monitor approximately 8300 evacuees in a 12 hour1.388889e-4 days <br />0.00333 hours <br />1.984127e-5 weeks <br />4.566e-6 months <br /> time frame even if'4-more monitoring stations were added?

A. Based on my experience, I cannot imagine how the logistical problems presented by an unselected mixed population of this size arriving at one of the Decontamination f acilities described in the Applicants' testimony could be dealt with in this kind of a time frame. It seems highly unlikely that such a large group could be successfully monitored within 12 hours1.388889e-4 days <br />0.00333 hours <br />1.984127e-5 weeks <br />4.566e-6 months <br /> in the f acilities described by the Applicants in their plan and testimony.

13. Q. Does that conclude your testimony?

A. Yes, it does.

4 1

. 4 n: '.

'e* .

CURRICULUM VITAE Name: Belton Allyn Burrows Born: March 3, 1918 Married: Dorinda McKenzie Burrows Chi ~1dren: Six Address: 50 Edgehill Road, Brookline, Mass. 02146 Degrees: A.B. Yale, 1939; M.D. Columbia, 1943 Membership in Scientific and Professional Organizations:

American Association of University Professors American Board of Internal Medicine American Clinical and Climatological Association American College of Physicians American Federation for Clinical Research American Society for Clinical Investigation American Society of Nephrology American Thyroid Association Endocrine Society Massachusetts Medical Society New York Academy of Science Norfolk District Medical Society Society of Nuclear Medicine American Board of Nuclear Medicine Hospital Appointments:

Intern, New Haven Hospital, July 1943 - April 1944 Asst. Resident in Medicine, New Haven Hospital, July 1946 - June 1947 Asst. Resident, Evans Memorial July 1947 - June 1948 Life Insurance Medical Research Fund Fellow, Evans Memorial, July 1948 - June 1950 Asst. in Medicine, Boston City Hospital, August 1948 -

Assoc. Visiting Physician, University Hospital (Mass. Memorial) June 1950 - -

Member, Evans, Memorial, June 1950 - ,

Senior Physician, Radioisotope Unit, Cushing VA Hospital Framingham, Mass., June 1950 - Sept. 1952 Senior Physician, Radioisotope Unit, Boston VA Hospital October 1952 - November 1953 Chief, Radioisotope Service, Boston VA Hospital November 1953 -

Acting Director, Nuclear Medicine Service, Veterans Administration Central Office, Sept. 1967 - 1973

41

~

g, - o y'< , .

4 ~;Q

>W '

,n . . .

L Curriculum VitacL B.A. Burrows, M.D.

N '

( \ 3

g. ' Military Service: 1 F( 1st Lieutenant;- April 1944 -June-1945 ,

Captain - July 1945 - June 1946,' Finney. General Hospital; i.

Thomasville, Georgia; Hoff General Hospital,  ;

Santa Barbara, California; 252nd General Hospital;.  !

7a 1st General Hospital;'126 1st. Engineer Combat Battalion; 1173 Engineer Combat Group; Post

Surgeon,. Engineer School, European Theatre.

AcademicLAppointments: . . .

i-Asst. in Medicine, Yale Medical School LJuly 19431- April 1944 Asst. in Medicine,' Yale Medical School-July 1946 - June 1947 1

Asst. in Medicine, Boston University School of Medicine i e nJuly 1947 - February 1950 .

Instructor in Medicine, Boston University School of Medicine l February 1950 - June .1950 .

Asst. Professor of Medicine, Boston University. School of

-Medicine, June 1950 - June 1957 Assoc. Professor of Medicine, Boston University School -

of Medicine, June.1957 - June 1965 Research Professor of Medicine, Boston University School. j f

  • of Medicine' July 1965 -

Consultant, Lemuel Shattuck Hospital,-Jamaica' Plain, Mass.

June 1955 - ,,

Consultant, Framingham Union Hospital, Framingham, Mass. .i 1960 - ,

Other: Member.1 Scientific . Advisory Committee, New England t Primate Center, '1965 - 1973 Member,JScientific Medical Founda' tion, Boston, 1966 - 1973- -

Trustec, -Society of Nuclear Medicine, 1964 --1972 Editor, Journal ~ of Nuclear Medicine, June, 1970 - 1975-Consultant, Nuclear' Regulatory Commiss' ion, 1977 - ' '

4 i

. 1 hi d 4

S s

.A'-J----..

4.

Bibliography' .Belton A. Burrows, M.D.

June 1974

1. Grossman, C.M. , Sappington, T.S. , Burrows, B. A. , Lavictes , P.H.

and Peters, J.P. Nitrogen metabolism in acute infections. J. Clin.

Invest. 24_:523-531, July 1945.

2. Danowski, T.S. , Elkinton, J.R. , Burrows , B. A. and Winkler, A.W.

Exchanges of sodium and potassium in familial periodic paralysis.

J. Clin. Invest. 27 :65-74,. January 1948,

3. Burnett, C.H. , Burrows, B. A. and Commons, R.R. Kidney function in ostcomalacia resulting from renal acidosis. J. Clin. Invest. 27; -

527, July 1948.

4 Burnett, C.H. and Burrows, B. A. Repair solutions in the treatment of acidosis and alkalosis. Med. Clin. N.A. pp.1293-1307, Sept. 1948.

5. Burnett , C.H. , Burrows , B. A. and Commons , R.R. The lack of corelation between glomerular filtration rate, and serum electrolyte concentration changes, urinary electrolyte excretion or edemn formation, following sodium loads in subjects with normal kidneys, glomerulonephritis, and the nephrotic syndrome. J. Clin. Invest. 28;773, July 1949.
6. Emerson, C.P. , Jr. and Burrows, B. A. The mechanism of anemia and its influence on renal function in chronic uremia. J. Clin. Invest.

28_:6,' 779, July 1949,

7. Wilkins,.R.W., Culbertson, J.W., Burrows, B.A., Tinsley, C.M.,

Judson, W.E., and Burnett, C.H. Antidiuresis and renal vasoconstriction following venous congestion of the limbs in normal hypertensive and splanchnicectomized subjects. J. Clin. Invest. [B:819, 1949.

8. Burrows, B. A. , Commons, R.R. and Burnett, C.H. Sodium and potassium excretion in patients with renal. insufficiency, Am. J. Med.

7j423, 1949.

9. Burnett, C.H. , Burrows , B. A. and Commons, R.R. Studies of alkalosis.

I. Senal function during and following alkalosis resulting from pyloric obst ruction. J. Clin. Invest. 29:169, 1950.

! 2-

'10. Burnett, C.H. , Burrows , B. A. , Commons , R.R. and Towery, B.T.

Studies of alkalosis. II. Electrolyte abnormalities in alkalosis resulting from pyloric obstruction. J. Clin. Invest. 39;175,1950.

'11. McKay, D.G., Burnett, G.H. and Burrows, B.A. Panhypopituitarism:

Case report correlating clinical and pathologic findings. J. Clin.

Endocrin. 10:540, 1950,

12. Burrows, B.A. and Sisson, J.H. The measurement of total body potassium by the radioisotope dilution technique. J. Clin. Invest. 29;801-802, 1950.
Bibliography - B.A. Burrows, M.D.

Page 2, June 1974

13. Judson, W.E., Epstein, F.J., Tinsely, C.M., Burrows, B.A. and Wilkins, R.W. The hemodynamic and renal functional effects of venous congestion of the limbs in patients with diabetes insipidus. J. Clin.

Invest. 29,:826-827, 1950.

14. Ingbar, S.H. , Relman, A. S. , Burrows, B. A. , Kass , E.H. , Sisson, J.H.

and Burnett, C.H. Changes in normal renal function resulting from ACTH and cortisone. J. Clin. Invest. 29,:824, 1950.

15. Burnett, C.H. , Greer, M. A. , Burrows , B. A. . Sisson, J.H. , Relman, A.S. , ,

Weinstein, L. A. , and Colburne, C.G. The effects of cortisone on the course of acute glomerulonephritis. N. E.J. Med. 243:1028-1032, 1950,

16. Ingbar, S.H. , Kass, E.H. , Burnett , C.H. , Relman, A.S. , Burrows , B. A.

and Sisson, J.H. The effects of ACTH and cortisone on the renal tubular

. transport of uric acid, phosphorus, and electrolytes in patients with normal renal and adrenal function. J. Lab. Clin. Med. 18:533-541,1951.

17. Burne tt , C.H. , Reiman, A.S. , Burrows , B. A. , Sisson, J.H. and Ingbar, S.H.

Renal excretion of hypertonic sodium solutions in Addison's Disease with observations on the effects of cortisone. Am. J. Med. 11,:238-239, 1951.

18. Ingbar, S.H. , Kass , E.H. , Burnett , C.H., Relman, A.S., Burrows, B.A. and Sisson, J.H. The effects of ACTH and cortisone on the renal tubular transport of uric acid, phosphorus, electrolytes in patients with normal renal and adrenal function. Proc. Second Clin. ACTH Conf., pp. 130-133, 1951,
19. Burrows, B.A. and Ross, J.F. The management of hyperthyroidism. Med.

Clin. N.A., pp. 1305-1321, Sept. 1951,

20. Burrows, B. A. , Ashley, M.M. and Sisson, J.H. Radioactive potassium distribution in metabolic disorders. J. Clin. Invest. 31:620, 1952.
21. 'Papper, S., Burrows, B.A., Ingbar, S.H. , Sisson, J.H. and Ross, J.F. -

The effects of 1-thyroxine sodium on non-toxic goitre, on myxoedema, and on the thyroid uptake 'of radioactive iodine. N.E.J. Med. 247:897-899, 1952.  ;

22. Burrows, B. A. , Dell, E.S. , and Ross , J.F. Radioactive iodine conversion ratio in thyroid diagnosis. Am. J. Med. 14:498, 1953.
23. Burrows, B. A. and Ross, J.F. The uptake of stable iodine compared with

'the serum protein-bound iodine concentration in normal subjects and patients with thyroid disease. J. Clin. Endocrin. 6 Metab. 13:1358-1368, 1953,

24. Burrows, B.A. Iodine metabolism in thyroid diagnosis. Boston Medical Quarterly 4_: November 3, 1953.

.c ,

l .

1. .

Bibliography - B.A. Burrows,'M.D.

Page 3, June 1974

25. Burrows, B. A. , Dell, E. , Graham, D. and Ross , J.F. 'the radioiodine uptake and the protein-bound iodine in treated hyperthyroidism. Clin.

Res. Proc. 1:20, 1953,

26. Burrows, B. A. , Denton, J. , Ferguson, B. and Ross, 'J.F. Changes in body potassium in hepatic decompensation. Clin. Res. Proc. 1:111, 1953,
27. liine, G.J. , Burrows , B. A. and Ross , J. F. Performance of scintillation counters in measurement of 1131 uptake by the thyroid gland. Tracerlog 5_6,:2, 6 1953. '
28. Burrows, B.A., Ashley, M.M. and Sisson, J.ll. Exchangeable potassium content in metabolic disorders. Clin. Res. Proc. 1:31, 1953.
29. Burrows, B.A. The relationship of thyroid hormone utilization to its serum level. J. Clin. Invest. 32 : 558, 1953.
30. Burrows, B. A. , Peters, T. and Ross, J.F. The tissue utilization of endogenous thyroid hormone in human subjects. J. Clin. Invest. 33:921, 1954,
31. Burrows, B.A.,lline, G.J. and Ross, J.F. The simultaneous determination of radiosodium, radiopotassium and radiosulphate spaces. Clin. Res. Proc.

2_:81, 1954.

32. Itine, G.J. , Burrows , B. A. , Apt, L., Pollycover, M., Ross, J.F. and Sarkes, L.A. Scintillation counting for multiple tracer studies.

Nucleonics 13:23, 1955.

33. lline, G.J. and Burrows , B. A. The application of scintillation counter spectroscopy to radioactive tracer techniques. Abstract, Proc. Int.

Conf, on the Peaceful Uses of Atomic Energy, Geneva, Switzerland, August,-1955. , ,,, ,

34. Burrows, B. A. and Ross, J.F. The use of radiosodium and radiopotiissium tracer studies in man. Proc. Int. Conf. on the Peaceful Uses of Atomic Energy, Genova, Switzerland, August, 1955.
35. Iline, G.J. , Burrows , B. A. , Apt , L., Pollycove, M., Ross, J.F. and Sarkes, L.A. Scintillation counting for multiple-tracer studies.

Nucleonics 13/2, 23, 1955.

36. Burrows, B.A., Davis, D.J., Kelly, J.F., Lewis, A.A.G., Ross, J.F.

The effects of surgical procedures on simultaneously determined radio-sodium, radiosulphate, and radiopotassium spaces in human subjects.

J. Clin. Invest. H:924-925, 1955.

37. Mitchell, M., Burrows, B.A. and Ross, J.F. The relationship between clinical and laboratory findings in hyperthyroidism and the response to radiolodine therapy. Clin. Res. Proc. 3_:121, 1955.

Bibliography - B.A. Burrows, M.D.

Page 4, June 1974

38. Peters, T., Burrows, B.A. and Lowell, F.C. Physical binding of insulin by gamma globulin from insulin-resistant subjects. Fed. Proc. 16:608, 1956.

-39. Hollander, W., Reilly, P., and Burrows, B.A. L subjects as indicated by the disappearance of labelled 1{gphatic flow from albumin in human the subcutaneous tissues. J. Clin. Invest. 35j713, 1956.

40. Lambie, A.T., Roy, A.M., Relman, A.S., Burrows, B.A. and Schwartz, W.B. .

-On the mechanism of rubidium-induced acidosis. Clin. Res. Proc. 4:128, ~

1956. .

41. Kunin, A.S., Roy, A.M.,

Dearbonn,

E.H., Burrows, B.A. and Relman, A.S.

A comparison of the renal transport of rubidium and potassium. Clin.

Res. Proc. 4: 136, 1956,

42. Relman, A.S., Lambie, A.T,, Roy, A.M., and Burrows, B.A. The nature of cation accumulation of muscle cells: Displacement of potassium by rubidium and cesima. Clin. Res. Proc. 4j150, 1956.
43. Mitchell. M.L., Burrows, B.A., Dell, E.S., Graham, D.E. The effect of thyroid stimulating hormone on the thyroidal iodine turnover. J. Clin.

Endocrinol. G Metab. J6_:976, July 1956,

44. Hino, G.J. and Burrows, B. A. Plastic well scintillation counters for 8- and Y-ray measurements, Abstract, Radiation Res. 5:482, 1956.
45. Hine, G.J., Burrows, B.A. and Ross, J.F. Thyroid uptake measurements.

Nucleonics 15/1:54, 1957.

46. Burrows, B.A., Peters, T., Lowell, F.C., Trakas, A.N. and Reilly, P.

Physical binding of insulin by gamma globulins of insulin-resistant subjects. J. Clin. Invest. 36:393-397, 1957.

47. Lambie , A.T. , Burrows , B. A. and Sommers , . S.C. Clinopathologic conference. -

Refractory anemia, agammaglobulinemia and mediastinal tumor. Am. J . Clin.

Path. 2,7_:444-452, April 1957. .

48. Relman, A.S. , Lambie, A.T. , Burrows , B. A. , and Roy, A.M. Cation accumula-tion by muscle tissue; the displacement of potassium by rubidium and cesium in the living animal. J. Clin. Invest. 16:1249-1256, August 1957.
49. Burrows, B.A. Tracer studies in medical diagnosis. Med. Clin. N. A.
p. 1181, Sept. 1957.
50. Hollander, W. , Chobani.an, C. and Burrows , B. A. Electrolyte and water metabolism essential, renal or steroid-induced hypertension. Circulation 15:893, Oct. 1957.
51. Chobanian, A., Burrows, B.A. and Hollander, W. Electrolyte and water metabolism in early congestivo heart failure. Circulation 15,:866, Oct. 1957.

o..-.g..-.. _.. . .

v. -

' Bibliography - B.A. Burrows, M.D.

Page 5, June 1974-

52. Englert, E., Ingelfinger, F.J. and Burrows, B.A. Duodenal-collections:

Quantitative unreliability and a method of correction. Clin.~Res. 6:32 January 1958.

'53. J. B. , Hine , G.J. and Burrows, B. A. The use of carrier Diodrast Block,l31-Diodrast.

with I Clin. Res. 6_:38, January 1958.

54. Chobanian, A. , Burrows, B. A. and Hollander, W. The relationship of blood pressure to changes in body fluids and electrolytes in steroid hypertension.

Clin. Res. 6_:227, April, 1958. ,

55. Block, J.D. and Burrows, B.A. Renal clearance of I131-Diodrast at low plasma concentrations. Clin. Res. 6_:284, April, 1958.
56. Clifton, J. A. , Ingelfinger, F.J. and Burrows, B. A. The effect of cortisone and hydrocortisone on hepatic excretory function. J . Lab . 5

' Clin. Mad. 5J: 701-708, May 1958,

57. Slingerland, D.W., Dell, E.S., Graham, D.E., Trakas, A.P. and Burrows, B.A.

Thyroid secretion of nonthyroxine iodine. J. Clin. Invest. 37_:932, June 1958.

58. Burrows, B.A. Goiter diagnosis and treatment. Med. Clin. N.A. pp.1291-1303, Se'p t . 1958,
59. Block, J.B. , Hine, G.J. and Burrows, B. A. The use of carrier diodrast with I l31-Diodrast. Abstract, Clin. Res. 6,:38, 1958.
60. Hine, G.J. and Burrows, B.A. Total and partial body radioactivity measure-ments for metabolic tracer studies. Proc. Second United Nations Int.. Conf.

on Peaceful Uses of Atomic Energy, Vol. 26:213, 1958.

61. Hine, G.J. and Burrows, B.A. External body counting for radidisotope distribution studies. Abstract, Radiation Res. 9:129, 1958. ,

c -

-I2. Ja'gger, P. I. , Hine, G.J. , Cardarelli, J. A. and Burrows, B. A. Effects of dietary sodium on "exachangeable" sodium. Abstract, Clin Res. 7:283, 1959,

63. Jagger, P. I. , Block, J.B. an'd Burrows, B. A. Hepatic transport of 1131-Diodrast.

Clin. Res. 7_:34, January, 19591

'64. Block J.B., Graham, D.E. and Burrows, B.A. Theinfluenceofproteinbingng on Il 1-Diodrast excretion. J. Clin. Invest. 36_:988, June , 1959.

65. Hine, G.J., Jagger, P.I. and Burrows, B.A. External body counting for radio-isotope distribution studies. Abstract, 9th Int. Congress Radiology, Munich, July 1959.
66. Block, J.B., Burrows, B.A. Diagnostic use of 1131-Diodrast in hypertension due to unilateral renal disease. Circulation 18,:696, October, 1959.
67. Hine, G.J., Cardarelli, J. and Burrows, B.A. External body counting for radioisotope distribution studies. J. Lab. 6 Clin. Med. 55:476-485, March 1960.

C w.

-a

~

3. . ,

Bibliography - B. A. ~ Burrows, 21.D.

Page 6, June 1974

68. . Jagger. P. I. , Hine, G.J. , Cardarelli, J. A. and Burrows , B. A. Sodium 22 i

f equilibrium and exchangeable sodium determinations in edematous patients.

!! Clin'. Res:. S:229, April 1960.

69. Hine, G.J. , Jagger, P. I. , Burrows, B. A. and Cardarelli, J. A.  :

< Measurement of body-radioactivity for studies of sodium metabolism.

'J. Lab. - 6 Clin. Med, g
476, May 1960.

70.- Burrowr,' B. A. , Slingerland, D.W. , Liuzzi, A. , Dell, E.S. and Graham, D.E.

  • Thyroidal iodide secretion. ' J. Clin. -Invest. 3,9,:975 June,1960. ,

5

71. .J. and Burrows, B.A. Effects of carrier Diodrast i Block, on J.D. , Itine13g-labelled excretion of 1 Diodrast. -J.- Lab. 6 Clin. Med. 56:110, t

~~~

July 1960.

72. Englert, E. , Jr. , Burrows, B. A. and Ingelfinger, F.J. ' Differential analysis .

of the stages of hepatic excretory function with gamma emitting isotopes;  ;

i I. Methods and validation. J. Lab. 6 Clin. Med. 56,1181-192, August, 1960.

l 73. Englert, E. , Jr. , Burrows, B. A. and Ingelfinger, F.J. Differential analysis

!- of the stages of hepatic excretory function with gamma emitting isotopes; II. . Clinical results. J. Lab. & Clin, Med. 56,: 193, August, 1960.

74 Block, J.B. an Influence of scrum protein binding on renal ,

clearance of 1p3gurrows,

-LabelledB.Diodrast.

A. J. Lab. 6 Clin. Med. 56,t463, Sept. 1960.

75. Block, J.B. , !!ine, G.J. and Burrows, B. A. 113I-Diodrest studies in unilateral renal disease.- Circulation 2,2,:913 2 November 1960.
76. Hollander, W., B.A. Lymphatic t' low in human subjects as indicated byReilly, P. and Burrows,l31-labelled the disappearance of I albumin from the subcutaneous tissues. J. Clin. Invest. Feb. 1961. ,

7 7. - Hollander, W. , Chobanian, A.V. , and Burrows, B. A. Body fluid and electrolyte composition in arterial hypertension. I. ' Studies in essential, renal and malignant hypertension. J. Clin. Invest. 40:408-415. Feb. 1961. ,

78. Chobanian, A.V., Burrows, B.h. and Hollander, W. Body fluid and electrolyte Studies in mineral-corticoid composition in arterial hypertsnsion. II.

hypertension. J. Clin. Invest. 40,:416-422, 0 Feb. 1961.

79. Farmelant, M.H. and Burrows B.A. Urine flow response to mannitol loading in unilateral renal disease. J. Clin. Invest, g:1037, June 1961.
80. Chobanian, A.V., Burrows, B.A. and llo11ander, W. Body fluid and electrolyte composition in cardiac patients with severe heart disease but without peripheral edema. Circulation ,2_4:748-753, 1961.
81. Fordtran, J.S. , Levitan, R. , Bickerman, V. and Burrows, B. A. Kinetics of water absorption in the human intestine. Trans. Assoc. Amer. Phycns. 74,: 4 1961.

L i

~

l

~

- o f , , ,

l .

Bibliography B. A. Burrows. M.D..

'Page 7, June'1974

82. Hine, G.J., Jagger, P.I. and Burrows, B.A. Use of clinical body counter for ,

Int. Atomic long term cxchangeable sodium studies, "Whole-Body Cmmting".

Energy Agency, Vienna, P. 413-426, 1962. ,

l

, 83. Iline, G.J. , Farmelant, M.fl. , Burrows, B. A. and Cardarelli, J. A. Four-channel

  • magnetic tape recording and digital integration analysis of radiohippuran renal function tests. J. Nuclear Med.- 3:219, 1962 (Abstr.)

84 Chobanian, A.V. , Burrows , B. A. , llo11ander, W. Body cholesterol metabolism

  • l p in man. II. Measurement of body cholesterol miscible pool and turnover rate.  !

J. Clin. Invest. 41,:1783, 1962. [

85. Levitan, R. , Fordtran, J.S. , Burrows, B. A. and Ingelfinger, F.J. Wa'ter and salt absorption in-the human colon. J. Clin. Invest. 41,:1754, 1962. -

.86. Slingerland..D.W. and Burrows, B.A. Inhibition by propylthiouracil of the I

!- peripheral metabolism of radiothyroxine. J. Clin. Endocrinol. 6 Metab. 22,: i 511, 1962.

87. Slingerland. D.W. and Burrows, B.A. A probable abt.ormality in interthyroidal  :

iodine metabolism in hyperthyroidism. J. Clin. Endon inol. G Metab. 22,:368, L. 1962. "

R ,  :

(- 88. Hine, G.J., Farmelant, M.ll., Cardarelli, J.A., and Burrows, B.A.- Four channel

! magnetic tape recording and digital analysis of radio-hippuran renal function.

tests in normal-subjects. .'. Nuclear Hed. 4,,:371, 1963.

89. Burrows, B.A. Aldosterone, in The Practioner 190:272, 1963.
90. Jagger, P. I. , Iline, G.J. , Cardarelli, J. A. and Burrows, B. A. Influence of sodium intake on exchangeable sodium in normal human subjects. J. Clin.

Invest.~ 42,:1459, 2 1963.

91. Farmelant, M.H., Lipetz, C.A., Bikerman, V., and Burrows, B.A. Radioisotopic renal function studie's and surgical findings in 102 hypertensive patients.

-Am. J. Surg, 107:50, 1964 <

~ 92. Farmelant, M.H., Sachs, C., Genna, S. and Burrows, B.A. Physiological basis [

of radioisotopic renal function studies. Clin. Res. 1,2,:251, 2 1964.

93. Farmelant, M.H. , Sachs, C.E. , Hine, G.J. and Burrows B. A.- Use of radio-isotopic renal function studies to select patients for surgery in renal '

arterial stenosis. J. Clin.. Invest. 4_3,:1308, 3 1964.

94. Tyson, I., Bickerman, V., and Burrows, B.A. Potassium deficit in hyper-A tensive patients. Clin. Res. 12198. 1964. .
95. Genna, S., Dukstein, W., Jones, R. and Burrows, B.A. Whole body counting of non-uniformly distributed radioisotopes. J. Nuclear Med. 5_:364, 1964

,- l n

y  ;

3

' Bibliography - B.A. Burrows, M.D.

i ' Page S. June 1974 -

96[ Cardarelli, J. A. , Mulvey P.F., Jr., Murphy, C., Cooper, R., and Burrows, B.A.

Sensitivity of Bremsstrahlung activation analysis for iodine determination.

J. Nuclear Med. 6_:344, 1965.

p l

97. .Farmela g M.H., Dukstein, W.G. and Burrows, B.A. An effect of mannitol on renal I -hippuran excretion independent of urine-flow rate. J. Clin. Invest. ,

4_4,: 1045, 1965.

98. Burrows, B.A., Tyson, I., Dukstein W.G. and Genna, S. Clinical measurements '  :

L of body radioactivity. Transactions of the American Clinical and Climatological . 'f  !

Association, Vol. 77,:25, 1965.  :

99._. Hine, Gerald J., Genna, Sebastian and Burrows, B.A. Geometrical and attenua-

^

6 tion corrections for a two crystal whole body counter: Body scanning with an  :

l 8 x 4 in. NaI crystal. Radioactivity in Man, G.V. Meneely, Ed., C.C. Thomas, ' '

Springfield, 111., p. 135, 1965. ,

100. Burrows, B.A. and Farmelant, M.H. The use of radioactive isotopes in the ,

diagnosis of hypertension. Progress in Cardiovascular Disease, 8: 159-169, 1965. i 101. Burrows, B. A. , Mulvey, P.F. , Jr. , Cardarelli, J. A. and Cooper, R. Bremsstrah-j

. lung Activation Analysis of Iodine and Mercury. Radioactive Isotope in Klinik- '

und Forschung, 7:365, 1967. ,

-102. Burrows, B. A. , Farmelant, M.H. , Ingelfinger, F.J. , Relman, A.S. , and Finland, M.

Controversies in Internal Medicine, W.B. Saunders, Philadelphia, p. 379, 1966. "

103. Mulvey, P., Cardarelli, J.A., Zoukis, M., Cooper, R.D. and_ Burrows, B.A.

Sensitivity of Bremsstrahlung activation analysis for iodine determination.

J. Nucicar Med. 7:603, 1966. ,

104. Burrows, B.A. (Critical Review) From Radiation Lab to Clinic. Medical Opinion and Review, 1:40, 1966.

105. Tyson, B. h Genna, S.', Jones, R.L. , Bikerman, V. , Graham, R. , and.4brrows B. A.

Electrolyte studies.with a total body counter.

  • Physics in ' Medicine and Biology R: 168, 1966. .

106. Tyson, I., Genna, S., Jones, R.,L., Bikerman, V and Burrows, B.A. Studies of potassium depletion using measurements of total body potassium and body N fluid compartments. J. Clin. Invest. 4_5,:1081, 5 1966.

107. Farmelant, M.H. , Bakos, C. and Burrows B. A. Evaluation of nephron disparity in the dog and the ii. fluence of hypotension and osmotic loads. J. Clin. Invest.

4_6,:1954, 6 1967.

108. Farmelant, M.H. , Genna, S. , Sachs, C. and Burrows, B. A. Physiological verifica-tion of a' model for interpretation of the renogram. J. Nucl. Med. 9:314, 1968.  ;

109. Genna, S. and Burrows, B.A. Design and performance of " constant-resolution" focussing collimator. J. Nucl. Med. 9:318, 1968.

L --

r- u. 1 e ,

. Bibliography - B.A. Burrows, M.D.

Pcge 9, June 1974 1 110. Farmelant, M.ll.. Bakos. C. and Burrows B.A. Response of renal transit -

time to variations of renal blood flow and solute excretion. J. Clin.

g Invest. 42 : 328, 1968.

r 111'. Farmelant, M.li., Sachs, C.E., Genna, S. and Burrows, B.A. A physiological

[ model for renal excretion of labelled compounds. J. Nucl. Med. 1,0,:664. 0 1969.  :

p .

p 112. Farmelant, M.ll., Bakos, K. and Burrows B.A. Physiological determinants l- , , of renal tubular passage times. J. Nucl. Med ,l_0,,:641, 0 1969.

[

J 113. Farmelant, M.ll., Sachs, C.E. and Burrows. B.A. The influence of tissue .

'l ,

background radioactivity on the apparent role of renal accumulation of '

[ radioactive compounds. J. Nucl. Med, l_1,:112, 1970. '

L 114.- Farmelant, M.ll and Burrows, B.A. Prognostic values of radioisotopic renal  !

function studies for prediction of cure in renovascular hypertension.

j J. Nuc1'. Med. 11,:743, 1970.

, 11S. Tyson, B.I., Genna, S., Jones, R.L., Bikerman, V. and Burrows, B.A.

,, Body potassium measurements with a total body counter. J. Nucl. Med,11:

255-259, 1970.

, 116. Tfson, B. I. , Genna, S. , Jones, R. L. , Bikerman, V. and Burrows, B. A.

F Studies of potassium depletion using direct measurements of tothi body potassium. J. Nucl. Med. J1: 426, 1970. i 117. . Genna, S. , Teager, it.M. , flunkar, D.B. and Burrows, B. A. Computer automated scintiscannin a, system. Phs. Med. Biol. l_5,:214, 5 1970, i: .

p 118. Genna, S., Farmelant, M.ll, and Burrows, B.A. Improved scintiscan resolution without sensitivity loss; " Constant-resolution" collimator. Medical Radio-

, isotope Scintigraphy. IAEA, Vienna, 561-574, 1969.

119. Farmelant, M.ll., bukstein, W., and Burrows, B.A. ' Influence of water and mannitol loads on radiohippuran renal function curves. J. Nucl. Med. 11:

- 186, 1970. '

120. Cardarelli, J. A. , Podolsky, S. and Burrows, B. A. Neutron activati n analysis of nonradioactive iodinated in'sulin. J. Nuclear Medicine 12
422, l'971.

121. Podolsky, S. , Zimmerman, ii.J. , and Burrows , B. A. Decreased growth hormone 1 and insulin response in normokalemic cirrhosis with potassium depletion. 1

'J. Nucl. Med. JJ: 386, 1971.

  • 122. Genna, S. , Teager, !!. . Shore,11.!! , and Burrows , B. A. Application of multi-window spectral analysis to dual radionuclide scintiscanning.

J. Nucl. Med. JJ:431, 1972. '

123. Genna, S. , Teager,11. , Shore,11.!!. . Zimmerman, S. , Pang, S.C. and Burrows.

B. A. - Four-view scintiscanning; image structuring through multi-window pulse. height. analysis. I.A.E.A. Symposium on Medical Radioisotope Scinti-graphy, Vienna, Austria, 1973, pp.133-154.

rW $m'4.g 4 I N

o..

9 Bibliography - B.A. Burrows, M.D.  ;

Page 10, June 1974 '

124. Podolsky, S. , 2immerman, ll.J. , Burrows, B. A. , Cardarelli, J. A. and  ;

Pattavina, C.G.: Potassium depletion in hepatic cirrhosis: A re-  ;

versible cause of impaired growth hormone and insulin response to stimulation. New Eng. J. Med. 288:644, 1973. -

125. 51.. md. D. Ward, Hershman, Jerome M., Dell, Elisabeth S. and Burrows, i Belt.i - yrotropin and PBI in radiciodine-treated hyperthyroid patients.

The J. C1., 1:ndocrin. 6 Metab. 35: No. 6, pp.912-917, Dec.1972.

126. Slingerland, D.W., Dell, E.S., and Burrows, B.A. The spectrum of thyroid i function after radioiodine treatment. Further advances in thyroid resea'rch.

Editors: K.Fe'11inger and R. Hofer, Publ. Verlag der Wiener Medizinischen  !

Akademie, 1971.-

  • 127. Farmelant,M.ll., Genna, S., Burrows. B.A. Renal function studies with a scintillation camera, in Medical Radioisotope Scintigraphy, Vol. 2, i Vienna, International Atomic Energy Agency, 1969, pp. 229-240.

128. Burrows, B.A. and Podolsky, S. Studies of Potassium depletion in hepatic  :

cirrhosis using a whole body counter program. Annual Meeting of European Society of Nuclear Medicine, Athens, Greece, Sept. 1973.

129. Farmelant, M.H., and Burrows, B.A. The Renogram: Physiologic basis and current clinical use. Seminars in Nuclear Medicine 4_:61-73, 1974.

130. Cardarelli, J. A. , Podolsky, S. and Burrows, B. A. Analysis of stable iodinated insulin by neutron-activation techniques. Int. J. of Applied Radiation and Isotopes,1970, Vol. 21, pp.513-517.

131. Podolsky, S. , Burrows, B. A. , Zimmerman, H.J. and Pattavina, C.G. Effect of chronic potassium depletion on growth hormone release in man. '

Excerpta Medica International Congress Series No. 244. Proceedings of the Second International Symposium, Milan, Italy, May S-7,1971.

Genna, S. , Pang, S. ,Ni:icnerman, S. , Burrows, B.

132. '

Dual Window Spatial -

Filtering. J. Nucl. Med. 1,5,:453, 5 1974.

133. McNeil, 3.J. , Varady, P. D. , Burrows , B. A. and Adelstein, S.J. Cost / Benefit analysis in renovascular disease. J. Nucl. Med. 1_5:516, 5 1974.

134. Podolsky, S. and Burrows, B.A. Clinical applications of whole body counting to determine body potassium,in cirrhosis and diabetes mellitus. First World Congress of Nuclear Medicine, Tokyo, Japan, Sept. 1974.

135. Burrows, B.A., Cardarelli, J.A., Slingerland, D.W., Pattavina, C.G., Dell, E.S.

Electrolyte Patterns in Acute Heart Failure. Annual Meeting of the Gesellshaft Fur Nuclearmedizin, Munich, Germany, Sept. 1974. >

?

e y

a

T '

N :,: ? *,  !

[ ,

-dibliogrcphy - B.A. Surrows, M.D.

p , ,

- Page ll, Juno 19 76 ,

I; 136.' Podolsky, S. and Burrows, B.A. Development of impaired glucose tolerance "

L, and insulin and growth hormone secretion with hepatic decompensation and  !

I decreased body potassium. Clin. Res. 21 980, 1973.

l 137. Slingerland, D.W. , Sullivan, J. , Dell E. , and Burrows, B. A. Effects of

! TPJi in hyperthyroid patients treated with antithyroid drugs. Excerpta (

-Medica 361:78, 1975 (Abstr.) <

138. Slingerland, ' D. Ward, Sullivan, J.J. , Dell, E.E. , Burrows , B. A. Thyroid .

I t Suppression Tests During Drug Treatment of Hyperthyroidism. Clinical .:

L Endo. 5:415-418, 1976.' .

139. Genna, S. , Pang, S.C. , and Burrows, B. A. Application of fan reconstruction

F. geometries to transmission and emission systems. (In) TerPogossian MM, Phelps.ME, Brownell GL, ed. Workshop on Reconstruction Tomography in 'l_

Diagnostic Radiology and Nuclear Medicine, San Juan, Puerto Rico, 17-19 Apr.

p 1975, New York, University Park Press (to be published).

140. Burrows, B.A. and Slingerland D.W. Prolonged Drug Treatment of Hyper-thyroidism. Clin. Res. 24: No. 3, April 1976.

141. McNeil, B.J., Varady P.D., Burrows, B.A., et al. Measures of clinical efficacy. Cost effectiveness calculations in the diagnosis and treatment of hypertensive renalvascular disease. N.E.J.M. 293:216-221, 1975.

142. Genna, S. and Burrows, B.A. Analysis of an Arcuate Gamma Camera Design for Transaxial-Reconstruction. Proc. lAEA Meeting on Medical Radionuclide laaging, Los Angeles, Calif., October 25-29, 1976.

143.- Burrows, B.A. and Slingerland, D.W. Prolonged Drug Treatment of Hyperthyroidism.

Am. Clin. & Climatological Assoc. Meeting, Ponte Verda Beach, Florida, p- October 24-27, 1976.

144. Burrows, Belton A. and Slingerland D. Ward Prolonged Drug Treatment of Hyperthyroidism. Transactions of the American Clinical & Climatological y Association, Vol. 88, pg. 219-226,1976.

L :[ 145. Podolsky, S., Melissinos', C. and Burrows, B.A. Potassium depletion in fatal diabetic ketoacidosis: High serum potassium with low body potassium and similar skeletal muscle and myocardial potassium values. Diabetes 23:381 L (Suppl 1) 1974.

146. Podolsky, S. and Burrows, B.A. Comparison of "L-Sparing" and K-Losing" diuretic Regimens in Antihypertensive Therapy. Clin. Res. 25:508A, 1977 (Abstr.)

147. Burrows, B. A. and Podolsky, S. , Burney, S.W. , Cardarelli, J. A. and Genna, S.  ;

Effects of Long-term Antihypertensive Diuretic Therapy on Serum and Body Potassium. Clin. Res. 25:525A,1977 (Abstr.)

148. Burrows , B. A. , Podolsky , S. , Burney, S.W. , Morley, D.P. , Cardarell1, J. A. ,

and Genna, S. Body Potassium Changes with Antihypertensive Diuretic Therapy.

J. of duel. Med. 19: 721, 1978 (Abstr.) '

L

"V

s. ,

,Bibl: 1gre;phy - B.A..Eurrows. M.D.

~ Puge ,12 1494 'Podolsky, S., Burrows, B.A. Development of Impaired Clucose Tolerance and

( 3 Decreased Insulin and Crowth llormone Secretion with llepatic Decompensation

and Reduced !)ody Potassium. Diabetes 2_6
411, 1977 (Abstr.)

s b 150, 'Genna, S., Pang, S.C., Burrows, B.A. Analysis of an-Arcuate Gamma Camern Design for Transaxial Reconstruction. Medical Radionuclide Imaging, Vol. 1 L pg. 323-339. IAEA, Vianna,1977.

r 151. Cenha, S., Pang, S.C. and Burrows, ll.A. Application of fan _ reconstruction geometries to transmission and emission systems. (In) TerPogossian, !P1, Phelps, M.E. llrownell, C.L., eds. Reconstruction' Tomography in Diagnostic

  • Radiology and Nuclear Medicine. University Park Press, Baltimore, Md., 1977,

% pp. 139-154. ,

F h

152, Podolsky, S. and Burrows, B.A. Severity of' potassium depletion in hyper-osmolar non-ketotic diabetic coma. Cerontologist 17,:108,1977 (Abstr.)

I t153, Podolsky,'S. and Ilurrows, B.A.: Does long-term diuretic therapy of hyper -

E . tension cause potassium depletion 7 Effects of "K-Losing" and "K-Sparing" W diuretic regimens on scrum'an:' body potassium in essential _hypertenation, j Prevent. Ited. 7: .123, 1978 (Abstr.)

p -154. Podolsky, S. and Burrows, !!.A.: Total body and scrum potassium changes in f) '_'K-losing" and "K-sparing" antihypertensive regimens. Clin. Res. 26,: 593A, 1978.(Abstr.)-

f -155. 11urrows, B. A. , and Podolsky, S. : Does Long Term Diuretic Therapy of b Hypertension cause Potassium Depletion 7 Effects of "K-Losing" and "K-Sparing" Diuretic Regimens on Serum and Body Potassium-in Essential flypertension.

National Conf. on High Blood Pressure Los Angeles, Calif. 4/2-4/4/78.

I. 156. Podolsky, Stephen and. Burrows, Belton A.: Total Body and Scrum Potassium L

Changes in "K-Losing" and "K-Sparing" Antihypertensive regimens. Seventh Annual Meeting of the American College of Clinical Pharmacology, i

San Francisco, Calif. 4/27-5/2/78.

! f Burrows. B.A., Podolsky', S., Cardarelli, J.A., Burney, S.W., Morley, D.P.

L" 5157. and'Genna, S.r Body Potassium Changen tTith Antihypertensive Diuretic Therapy.

25th Annual Meeting of the Society of Nuclear Medicine, Anaheim, Calif.

6/25-30/78. -

L158...Podolsky, S., and Burrows, ll.A.: Comparison of "K-Sparing" and "K-Losing" Diuretic Regimens in Antihypertensive Therapy. XIth International Congress of Corontology, Tokyo, Japan, 8/20-25/78.

/!  ; d9. ' Burrows, B. A. , Podolsky, S. , Cardarelli, J. A. , Burney, S.W. , Moricy, D.P.

and Cennt.. S.: . Body potassium changes with antihypertensive diuretics.

World Fed. of Nucl. Med, and Biology Meeting, Washington, D.C. , Sept. 1978.

I  ; 160. - Burrows, B.A., Podolsky, S., Cardarelli, J.A., Ilurney, S.W., Morley, D.P.

and Conna, S. Body potassium changes with ant 1 hypertensive diuretic therapy.

.J. of Nucl. Med, j9,:721, 1978.

^

5

p -

' 7b a

~

( .._

Bibliography - B. A. Burrows, M.D.

Page 13

[.

I 161. Burrows, B. A. , Podolsky, S. , Cardarelli, J. A. , Burney, S.U. , Horley, D.P. ,

and Genna, S. Body Potassium Changes with ant 1 hypertensive diuretics.

World Fed. of Nucl. Med and Biology,1978, pg.137.

162. Podolsky, S., and Burrows, B.A. Effects of once daily diuretic therapy on body K and serum K levels in essential hypertension. Gerontologist 18:

112, 1978. .

D 163. Slingerland, D. Ward, Burrows, Belton A. Long-term antithyroid treatment

  • in hyperthyroidism. JAMA Vol. 242, No. 22, 2408-2410, 1979.

164. Podolsky, Stephen and Burrows, Belton A. Potassium Depletion: A cause of impaired carbohydrate tolerance in hepatic cirrhosis and other disease states. In Secondary Diabetes: The Spectrum of the Diabetic Syndromes, S. Podolsky and W. Viswanathan, eds, Raven Press, New York,1980, pp.437-448.

165. Burrows, B. A. , Cardarelli, John C., Boling, Eldon A. , and Sinex, F. Marott.

The medical effects of radioactive fall-out: role of stable end-products?

Trans. Am.' Clin & Clim. Assoc. , 1981, 92 227-33.

166. Borkan, G. A. , ilults, D.E., Cardarelli, J. A. , Burrows, B. A. Comparison of Ultrasound and Skinfold measurements in assessment of subcutaneous and total fatness. Am. J. Phys.-Anthrop. 58:307-313, 1982.

167. Borkan, G. A. , llults . D.E. , Gerzof, S.G. , Burrown, B. A. and Robbins , A.11.

Relationships between computed tomography tissue areas, thicknesses and total body composition. Ann. of Iluman Biology (in press).

p 168. Burrows, _ Belton A. , Cardarelli, John A., Sinex, F. Marott, Lefkin Howard L.

and Teager,-lierbert M. The Variability in Fallout Radionuclide Distribution Potential Radiochemical Damage. Trans. Am. Clin & Clim Assoc, 941 154-160, 1982.- ,

169. Cardarelli, John A., Burrows, Belton A., Miller, Aaron, Slingerland, D. Unrd Correction of attenuation in whole-body determination of Co-57 B12 absorp-tion. . J . Nucl. Med. 24: 949-951, 1983.

170.- Slingerland, D. Ward, Cardarelli, John A., Burrows. Belton A. , Miller - Aaron The utility of serum gastrin levels in assessing the significance of low serum B12 levels. Arch. Int:Med. 1984;144:116751168.

171. Konstantin N Pavlou, William P Steff ee, Robert H Lerman and Belton A Burrows Effects of dieting and exercise on lean body unss, oxygen uptake, and L

s t ieng th. Med. and Sci. in' Sports and Exercise Vol.17, No.4, Feb.1985.

17 2. Cardarelli, John A, Slingerland, D. Hard, Burrows, Belton A. and Miller, Aaron Measureinent of Total-Body Cobalt-57 Vitamin B12 Absorption with a Gamma Camera. J. of Nucl.Ned. Vol. 26, No. 8, Aug. 1985, 941-943.

t

~

y +

Bibliography - B., A Burr:.ws, 11.D.

> P c; lu 173  :* iller, A., S11ngerland, D.W., Burrows, B.A., Cardarelli, J.A.

The diagnostic evaluation of low serum vitamin B 12 Nuklearmedizin S upp.24 : 798, 1988.

174 Cardarelli, J. A. , Slingerland, D.W. , Miller, A. , Burrows, B. A.

Specially shicided gamma camera for measurement of B12 absorption.

European Nuclear Medicine Congress, Milano, 1988 (Abstr.)

175. iiiller, A. , S11ncerland, D.W. , Cardarelli, J. and Burr as, B. A.

Further studies on the use of cerum gastrin levcis in assessing the significance of low serum B12 levels. Am. J. of Hematology,1989 (In p:'ess) '

176. Surrows Belton A. , Chalmers, Thomas C. , and Cardarelli, John A.

Global Fallout Distribution in Fireplace Ashes. Trans. Am. Clin &

Clim. Assoc. 1989 (In press)  !

l 1

I

. i

.

Retrieved from "https://kanterella.com/w/index.php?title=ML20008D465&oldid=2475387"